MUDr. Rudolf Nenutil, CSc.
Total number of publications: 135
2009
-
Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis
Journal of Proteome Research, year: 2009, volume: 8, edition: 1, DOI
-
Cetuximab and irinotecan in metastatic colorectal cancer , drug response and its prediction: retrospective analysis
Year: 2009, type: Conference abstract
-
Clinicopathological correlations of cyclooxygenase-2, MDM2, and p53 expression in surgically resectable pancreatic invasive cancer.
International Journal of Molecular Medicine 2009; 24: Suppl 1 - The 14th World Congress on Advances in Oncology and 12th International Symposium on Molecualr Medicine., year: 2009
-
Clinicopathological correlations of cyclooxygenase-2, MDM2, and p53 expressions in surgically resectable pancreatic invasive ductal adenocarcinoma
Pancreatology 2009; 98: S485 - 41st European Pancreatic Club Meeting ., year: 2009
-
Clinicopathological correlations of cyclooxygenase-2, MDM2, and p53 expressions in surgically resectable pancreatic invasive ductal adenocarcinoma.
Pancreas, year: 2009, volume: 38, edition: 5
-
Expression of p53, cyclin D1 and EGFR correlates with histological grade of adult soft tissue sarcomas: a study on tissue microarrays
Neoplasma, year: 2009, volume: 56, edition: 3
-
Expression pattern of HLA class I antigens in renal cell carsinoma and primary cell line cultures: Methodological implications for immunotherapy
Medical Science Monitor (International Medical Journal of Experimental and Clinical Research), year: 2009, volume: 15, edition: 12
-
Prediction of human papillomavirus 16 e6 gene expression and cervical intraepithelial neoplasia progression by methylation status
International Journal of Gynecologic Cancer, year: 2009, volume: 19, edition: 3
-
Regulátory buněčného cyklu u sarkomů měkkých tkání
Year: 2009, type: Conference abstract
-
Výsledky retrospektivní analýzy cílené léčby metastatického karcinomu prsu trastuzumabem v MOÚ. Identifikace prediktivních faktorů.
Klinická onkologie, year: 2009, volume: 21, edition: 6